ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
澳股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
新冠治疗股
849.038
+8.235
0.98%
涨家数：
6
跌家数：
13
平家数：
13
市盈率：
- -
高：
851.510
开：
836.855
低：
831.778
收：
840.804
成交量：
2,373.70万
成交额：
2.77亿
市值：
2,148.56亿
流通市值：
1,703.78亿
数据加载中...
总览
新闻资讯
CSL 表示出血性疾病基因疗法全球缺货
路透中文
·
03/18
CSL有限公司正与监管机构协作制定策略 确保Hemgenix持续稳定供应
美股速递
·
03/17
今日优惠-合并与收购
路透中文
·
03/17
CSL Seqirus将携手长期合作伙伴Sinergium Biotech 供应差异化流感疫苗组合
美股速递
·
03/10
3M公司(MMM)股票3月9日盘中下跌3.12%：原因全解读
TradingKey中文
·
03/10
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK7501/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"新冠治疗股","latestPrice":849.03845,"timestamp":1774241999980,"preClose":840.8039,"halted":0,"volume":23737012,"delay":0,"changeRate":0.009794,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":8.234558,"latestTime":"03-23 16:00:00 AEDT","open":836.85474,"high":851.5098,"low":831.7781,"amount":277278923,"amplitude":0.023468,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1774306800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1774220400000,1774242000000]],"turnoverRate":0.001653,"increases":6,"decrements":13,"flats":13,"marketCap":214855898315.5,"floatMarketCap":170377956328.58594},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":851.5098,"amplitude":0.023468,"preClose":840.8039,"low":831.7781,"latestPrice":849.03845,"volume":23737012,"delay":0,"open":836.85474,"prevYearClose":900.1661,"prevWeekClose":840.804,"prevMonthClose":875.89,"prevQuarterClose":900.166,"fiveDayClose":847.154,"twentyDayClose":853.35,"sixtyDayClose":912.343,"secType":"PLATE","market":"AU","turnoverRate":0.001653,"marketCap":214855898315.5,"floatMarketCap":170377956328.58594,"timestamp":1774241999980,"nameCN":"新冠治疗股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":6,"down":13,"flat":13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620471351","title":"CSL 表示出血性疾病基因疗法全球缺货","url":"https://stock-news.laohu8.com/highlight/detail?id=2620471351","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620471351?lang=zh_cn&edition=fundamental","pubTime":"2026-03-18 00:37","pubTimestamp":1773765430,"startTime":"0","endTime":"0","summary":"路透3月17日 - 澳大利亚CSLCSL.AX公司表示，其出血性疾病基因疗法Hemgenix面临暂时性全球缺货，这将推迟该药物在已上市国家的部分患者的治疗。医生们认为，高昂的价格、物流问题和潜在的治疗进展前景阻碍了血友病基因疗法的采用。CSL表示，推迟治疗可能会影响到一些符合条件的患者，这些患者原本计划在已上市的国家接受一次性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nL4T4051K5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999011175.SGD","BK7067","LU1894683348.USD","IE00BLSP4452.SGD","LU1066053197.SGD","BK4550","BK7511","LU0868494617.USD","BK7508","IE00BLSP4239.USD","LU1066051498.USD","LU0225284248.USD","BK4534","LU0321505439.SGD","LU0985481810.HKD","BK4581","SGXZ57979304.SGD","BK4588","SG9999013999.USD","LU0289739699.SGD","LU0225771236.USD","SG9999001176.USD","BK4599","IE00B19Z3B42.SGD","BK4007","LU0170899867.USD","CSL.AU","BK4568","IE00B19Z3581.USD","BK4533","LU0321505868.SGD","BK7501","SG9999002232.USD","LU0122379950.USD","IE0002270589.USD","LU0456855351.SGD","LU0234572021.USD","LU0306806265.USD","BK4592","SG9999001176.SGD","LU1894683264.USD","LU1057294990.SGD","SG9999002224.SGD","IE000M9KFDE8.USD","LU0306807586.USD","BK4585","LU1883839398.USD","IE00BBT3K403.USD","LU0058720904.USD","SG9999003800.SGD","LU1023059063.AUD"],"gpt_icon":0},{"id":"1128210509","title":"CSL有限公司正与监管机构协作制定策略 确保Hemgenix持续稳定供应","url":"https://stock-news.laohu8.com/highlight/detail?id=1128210509","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128210509?lang=zh_cn&edition=fundamental","pubTime":"2026-03-17 23:47","pubTimestamp":1773762439,"startTime":"0","endTime":"0","summary":"全球生物技术巨头CSL有限公司近日宣布，公司已启动与相关药品监管部门的密切沟通，共同探讨保障基因疗法Hemgenix长期稳定供应的战略方案。这一举措旨在应对潜在供应链挑战，确保这款突破性血友病B治疗药物能够持续满足全球患者的临床需求。通过建立多方协作机制，CSL将优化从原料采购到成品配送的全链条管理。此次战略合作凸显了CSL对患者用药可及性的长期承诺。CSL将通过技术创新与监管协作的双重路径，持续推动罕见病治疗领域的进步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CSL.AU","BK7508","BK7511","BK7501"],"gpt_icon":0},{"id":"2620286284","title":"今日优惠-合并与收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2620286284","media":"路透中文","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620286284?lang=zh_cn&edition=fundamental","pubTime":"2026-03-17 17:45","pubTimestamp":1773740741,"startTime":"0","endTime":"0","summary":"今日优惠-合并与收购路透3月17日 - 截至格林尼治标准时间周二9:30，报导了以下竞标、兼并、收购和处置情况：** Woolworths < WHLJ.J > 说，它已同意收购私人控股的 in2food Holdings，收购金额未披露，这家食品和服装零售商的目标是更好地控制其优质方便食品的质量和供应。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nL4T4050SH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK1147","BK4603","BK7040","BK7123","WOW.AU","CGF.AU","BK7501","BK7160","BK7112","AVXX","BK4187","PPM.AU"],"gpt_icon":1},{"id":"1138284712","title":"CSL Seqirus将携手长期合作伙伴Sinergium Biotech 供应差异化流感疫苗组合","url":"https://stock-news.laohu8.com/highlight/detail?id=1138284712","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138284712?lang=zh_cn&edition=fundamental","pubTime":"2026-03-10 23:02","pubTimestamp":1773154962,"startTime":"0","endTime":"0","summary":"CSL有限公司旗下业务单元CSL Seqirus宣布，将与其长期合作伙伴Sinergium Biotech合作，共同供应其差异化的流感疫苗产品组合。此次合作旨在进一步拓展相关市场的疫苗可及性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7501","BK7508","CSL.AU","BK7067"],"gpt_icon":0},{"id":"2618678908","title":"3M公司(MMM)股票3月9日盘中下跌3.12%：原因全解读","url":"https://stock-news.laohu8.com/highlight/detail?id=2618678908","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618678908?lang=zh_cn&edition=fundamental","pubTime":"2026-03-10 00:16","pubTimestamp":1773072997,"startTime":"0","endTime":"0","summary":"• 地缘政治事件和谨慎情绪导致股价下跌。\n• 2026年财务前景平淡且仅符合市场预期，令股价承压。\n• 尚未解决的法律负债意味着重大的长期财务支出义务。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/stocks/261661214-market-movers-mmm-20260309","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","SG9999002232.USD","BK4533","LU2264538146.SGD","BK4534","BK4512","LU0683600562.USD","LU1894683264.USD","BK4588","SG9999002224.SGD","LU1093756168.USD","LU1064131342.USD","BK4206","BK4585","LU1894683348.USD","MMM.AU","MMM","BK7501","LU1988902786.USD","BK7040","BK7049","IE000M9KFDE8.USD","LU0787776722.HKD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}